{"id":14293,"date":"2016-10-08T00:58:52","date_gmt":"2016-10-08T04:58:52","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=14293"},"modified":"2016-10-08T00:58:52","modified_gmt":"2016-10-08T04:58:52","slug":"china-david-versus-goliath","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/","title":{"rendered":"China: David versus Goliath"},"content":{"rendered":"<p>Hong Kong&#8217;s Hang Seng Index respected its new support level at 23000, confirming the primary up-trend. Follow-through above 24000 would offer a target of 26000*.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Hang Seng Index\" alt=\"Hang Seng Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The Shanghai Composite Index, on the other hand, continues to wander aimlessly between 2800 and 3100.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Shanghai Composite Index\" alt=\"Shanghai Composite Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2016\/2016-10-08-ssec.png?w=525&#038;ssl=1\" \/><\/p>\n<p>With China&#8217;s one-country-two-systems we have a clear long-term comparison between the two systems: a centrally-planned, authoritarian and increasingly nationalistic Goliath and a more democratic, outward-looking, free-market David in Hong Kong. My money is on the little guy. <\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Hang Seng Index &amp; Shanghai Composite Index\" alt=\"Hang Seng Index &amp; Shanghai Composite Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi-ssec.png?w=525&#038;ssl=1\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hong Kong&#8217;s Hang Seng Index respected its new support level at 23000, confirming the primary up-trend. Follow-through above 24000 would offer a target of 26000*. The Shanghai Composite Index, on the other hand, continues to wander aimlessly between 2800 and 3100. With China&#8217;s one-country-two-systems we have a clear long-term comparison between the two systems: a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;China: David versus Goliath&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[41,57],"tags":[],"class_list":["post-14293","post","type-post","status-publish","format-standard","hentry","category-china-hk","category-stock-markets"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>China: David versus Goliath - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China: David versus Goliath - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Hong Kong&#8217;s Hang Seng Index respected its new support level at 23000, confirming the primary up-trend. Follow-through above 24000 would offer a target of 26000*. The Shanghai Composite Index, on the other hand, continues to wander aimlessly between 2800 and 3100. With China&#8217;s one-country-two-systems we have a clear long-term comparison between the two systems: a &hellip; Continue reading &quot;China: David versus Goliath&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-08T04:58:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"China: David versus Goliath\",\"datePublished\":\"2016-10-08T04:58:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\"},\"wordCount\":77,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png\",\"articleSection\":[\"China &amp; HK\",\"Stock Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\",\"name\":\"China: David versus Goliath - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png\",\"datePublished\":\"2016-10-08T04:58:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China: David versus Goliath\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"China: David versus Goliath - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"China: David versus Goliath - the patient investor","og_description":"Hong Kong&#8217;s Hang Seng Index respected its new support level at 23000, confirming the primary up-trend. Follow-through above 24000 would offer a target of 26000*. The Shanghai Composite Index, on the other hand, continues to wander aimlessly between 2800 and 3100. With China&#8217;s one-country-two-systems we have a clear long-term comparison between the two systems: a &hellip; Continue reading \"China: David versus Goliath\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2016-10-08T04:58:52+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"China: David versus Goliath","datePublished":"2016-10-08T04:58:52+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/"},"wordCount":77,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png","articleSection":["China &amp; HK","Stock Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/","name":"China: David versus Goliath - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png","datePublished":"2016-10-08T04:58:52+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2016\/2016-10-08-hsi.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/08\/china-david-versus-goliath\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"China: David versus Goliath"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3Ix","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":6143,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/13\/china-hong-kong-divergence\/","url_meta":{"origin":14293,"position":0},"title":"China &#8211; Hong Kong divergence","author":"Colin Twiggs","date":"November 13, 2012","format":false,"excerpt":"Divergence between the Shanghai Composite Index and Hong Kong's Hang Seng Index is apparent over the last 12 months, with Hong Kong rebounding while Shanghai weakens. With no major changes in the HKDCNY exchange rate, to me this reflects political and economic instability on the mainland.","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4247,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/30\/hong-kong-china-3\/","url_meta":{"origin":14293,"position":1},"title":"Hong Kong &#038; China","author":"Colin Twiggs","date":"April 30, 2012","format":false,"excerpt":"Dow Jones Hong Kong Index is holding above support at 410. Respect of support would confirm the primary up-trend already signaled by a 63-day Twiggs Momentum cross above zero. The Hang Seng similarly respected support at 20000, indicating a primary up-trend, while rising 13-week Twiggs Money Flow indicates buying pressure.\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4355,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/05\/15\/china-hong-kong-5\/","url_meta":{"origin":14293,"position":2},"title":"China &#038; Hong Kong","author":"Colin Twiggs","date":"May 15, 2012","format":false,"excerpt":"The Shanghai Composite Index is retreating from primary resistance at 2500. Reversal of 63-day Twiggs Momentum below zero warns of continuation of the primary down-trend. Recovery above 2500 is unlikely but would signal the start of a primary up-trend. Hong Kong's Hang Seng Index reversed below primary support at 20000\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3432,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/02\/06\/china-hong-kong\/","url_meta":{"origin":14293,"position":3},"title":"China &#038; Hong Kong","author":"ColinTwiggs","date":"February 6, 2012","format":false,"excerpt":"Shanghai Composite Index is testing resistance at 2300 but there is no clear breakout from the trend channel to indicate a trend change. Respect would signal a down-swing to test the lower trend channel around 2000*. * Target calculation: 2150 - ( 2300 - 2150 ) = 2000 Hong Kong's\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3865,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/03\/18\/hong-kong-china-2\/","url_meta":{"origin":14293,"position":4},"title":"Hong Kong &#038; China","author":"Colin Twiggs","date":"March 18, 2012","format":false,"excerpt":"Hong Kong's Hang Seng Index is in a primary up-trend. Having retraced briefly, it appears to have found support at 21000. Recovery above 21500 would signal an advance to 22500*. * Target calculation: 20000 + ( 20000 - 17500 ) = 22500 The Shanghai Composite Index, however, remains in a\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":9425,"url":"https:\/\/thepatientinvestor.com\/index.php\/2014\/03\/08\/china-will-never-support-putin-on-crimea\/","url_meta":{"origin":14293,"position":5},"title":"China will never support Putin on Crimea","author":"ColinTwiggs","date":"March 8, 2014","format":false,"excerpt":"Offering the people of Crimea a referendum -- on whether to secede from Ukraine and join the Russian Federation -- may appeal to Vladimir Putin but he should not expect support from China. For two very simple reasons: Hong Kong and Taiwan. China claims these two territories as part of\u2026","rel":"","context":"In &quot;China &amp; HK&quot;","block_context":{"text":"China &amp; HK","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/china-hk\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=14293"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14293\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=14293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=14293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=14293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}